Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for Mild Cognitive Impairment in Parkinson's Disease
2022-001751-17Phase 2Active
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Donepezil with Placebo (2 arms). Primary endpoint: Parkinson's Disease-Cognitive Rating Scale (PD-CRS). Started Jan 2023; status: active.
02
Drugs
donepezil
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2022-001751-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-001751-17.